In pancreatic cancer cells, reductions in KDM6A lead to the increased expression of activin A, a member of the transforming growth factor-β superfamily of cytokines that activates a noncanonical p38 MAPK pathway to induce mesenchymal identity [120] and promote EMT [175,176]. This evidence concerns the gene KDM6A and pancreatic neoplasm.